NCT00121069View on ClinicalTrials.gov

Study of Escitalopram in the Treatment of Specific Phobia

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

September 30, 2004

Conditions

Phobic Disorders

Interventions

DRUG

Escitalopram

Trial Locations (1)

27710

Dept of Psychiatry and Behvaioral Science, Duke Unviersity Medical Center, Durham

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Connor, Kathryn M., M.D.

INDIV